Dario A. Paggiarino, Chief Medical Officer at EyePoint Pharmaceuticals, Inc. (EYPT), sold 22,037 shares at $25.02 ($551K) on 2024-01-24, disclosed to the SEC on 2024-01-25.
Open-market sale of $551k EYPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 2,039 | $51K | 9.2% |
| 2 | $25.00 | 3,096 | $77K | 14.0% |
| 3 | $25.01 | 5,600 | $140K | 25.4% |
| 4 | $25.02 | 5,651 | $141K | 25.7% |
| 5 | $25.02 | 5,651 | $141K | 25.7% |
| Total | $25.01 avg | 22,037 |
| $551K |
| 100% |
| Filing → |
| EYPT | SELL | 2024-01-10 | $968K | — | Filing → |
| EYPT | SELL | 2023-12-15 | $29K | — | Filing → |
| EYPT | SELL | 2023-12-06 | $674K | — | Filing → |